北美心脏移植市场预测至 2030 年 - 区域分析 - 按手术类型(原位心脏移植和异位心脏移植)、类型(供体活体心脏和人工心脏)和最终用户(医院、心脏中心等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 68    |    Report Code: BMIRE00030077    |    Category: Life Sciences

North America Heart Transplant Market
北美心脏移植市场预计将从 2022 年的 72.521 亿美元增长到 2030 年的 171.9272 亿美元。预计从 2022 年到 2030 年,该市场的复合年增长率为 11.4%。

AI 在移植程序中的应用推动了北美心脏移植市场的发展

由人工智能 (AI) 支持的独特设计的系统有助于检测心脏移植后宿主排斥的早期迹象和严重程度。心内膜心肌活检 (EMB) 筛查是识别心脏移植后同种异体移植排斥的标准护理。2022 年,一种新的 AI 系统被设计出来,称为心脏排斥评估神经估计器 (CRANE),可与医学评估结合使用,以快速准确地进行诊断。CRANE 还有助于减少宿主体内心脏排斥的存在和严重程度的差异。它是一个基于深度学习的 AI 系统,用于自动评估从 EMB 获得的千兆像素全幻灯片图像。2020 年,美国国立卫生研究院拨款 320 万美元用于探索 AI 在心脏移植中的能力。利用这笔资助,来自佩雷尔曼医学院(宾夕法尼亚大学)、凯斯西储大学、克利夫兰诊所和雪松西奈医学中心的研究人员旨在研究导致新心脏排斥的原因以及如何处理它。他们使用 AI 分析心脏活检组织图像,发现在新心脏排斥中起重要作用的免疫细胞类型。因此,在心脏移植手术中采用 AI 可能会在未来几年为市场带来新的趋势。

北美心脏移植市场概览

北美的心脏移植市场分为美国、加拿大和墨西哥。 2022 年,北美占据了最大的市场份额,市场增长可以归因于老年人口的激增、心血管疾病的流行以及心力衰竭病例的增加。慢性肾病发病率的增加和老年人口的增加是推动美国心脏移植市场增长的关键因素。根据美国心脏协会提供的数据,美国每年登记约 100 万例新的心力衰竭病例,预计到 2030 年将有超过 800 万人患心力衰竭。根据健康研究资助组织的数据,2021 年美国约有 555,000 人被诊断出患有心力衰竭初期。心血管疾病 (CVD) 通常会导致心力衰竭或终末期心脏病,这增加了对心脏移植的需求。

美国食品和药物管理局 (FDA) 越来越多地批准各种心脏移植程序和产品。此外,大公司的存在也使这个国家的市场受益。 2022 年 4 月,TransMedics Group, Inc. 获得了 FDA 对其 OCS Heart 的上市前批准。

北美心脏移植市场收入及预测至 2030 年(百万美元)

北美心脏移植市场细分

北美心脏移植市场细分为手术类型、类型、最终用户和国家/地区。

根据手术类型,北美心脏移植市场分为原位心脏移植和异位心脏移植。2022 年,原位心脏移植部分在北美心脏移植市场中占有较大份额。

就类型而言,北美心脏移植市场分为供体活体心脏和人工心脏。2022 年,供体活体心脏部分在北美心脏移植市场中占有较大份额。此外,人工心脏部分分为心室辅助装置和全人工心脏。

根据最终用户,北美心脏移植市场细分为医院、心脏中心和其他。 2022 年,医院部门占据了北美心脏移植市场的最大份额。

根据国家/地区,北美心脏移植市场分为美国、加拿大和墨西哥。2022 年,美国主导了北美心脏移植市场。

Terumo Corp、Evaheart Inc、Abbott Laboratories、SynCardia Systems LLC、BiVACOR Inc、BioVentrix Inc、Berlin Heart GmbH、LivaNova Plc、Jarvik Heart Inc 和 Calon Cardio-Technology Ltd 是北美心脏移植市场的一些领先公司。

North America Heart Transplant Strategic Insights

Strategic insights for North America Heart Transplant involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-heart-transplant-market-strategic-framework.webp
Get more information on this report

North America Heart Transplant Report Scope

Report Attribute Details
Market size in 2022 US$ 7,252.10 Million
Market Size by 2030 US$ 17,192.72 Million
Global CAGR (2022 - 2030) 11.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 手术类型
  • 原位心脏移植和异位心脏移植
By 类型
  • 供体活体心脏和人工心脏
By 最终用户
  • 医院
  • 心脏中心
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Terumo Corp
  • Evaheart Inc
  • Abbott Laboratories
  • SynCardia Systems LLC
  • BiVACOR Inc
  • BioVentrix Inc
  • Berlin Heart GmbH
  • LivaNova Plc
  • Jarvik Heart Inc
  • Get more information on this report

    North America Heart Transplant Regional Insights

    The regional scope of North America Heart Transplant refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-heart-transplant-market-geography.webp
    Get more information on this report

    The List of Companies - North America Heart Transplant Market

    1. Terumo Corp

    2. Evaheart Inc

    3. Abbott Laboratories

    4. SynCardia Systems LLC

    5. BiVACOR Inc

    6. BioVentrix Inc

    7. Berlin Heart GmbH

    8. LivaNova Plc

    9. Jarvik Heart Inc

     

    Frequently Asked Questions
    How big is the North America Heart Transplant Market?

    The North America Heart Transplant Market is valued at US$ 7,252.10 Million in 2022, it is projected to reach US$ 17,192.72 Million by 2030.

    What is the CAGR for North America Heart Transplant Market by (2022 - 2030)?

    As per our report North America Heart Transplant Market, the market size is valued at US$ 7,252.10 Million in 2022, projecting it to reach US$ 17,192.72 Million by 2030. This translates to a CAGR of approximately 11.4% during the forecast period.

    What segments are covered in this report?

    The North America Heart Transplant Market report typically cover these key segments-

  • 手术类型 (原位心脏移植和异位心脏移植)
  • 类型 (供体活体心脏和人工心脏)
  • 最终用户 (医院, 心脏中心)
  • What is the historic period, base year, and forecast period taken for North America Heart Transplant Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Heart Transplant Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in North America Heart Transplant Market?

    The North America Heart Transplant Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Terumo Corp
  • Evaheart Inc
  • Abbott Laboratories
  • SynCardia Systems LLC
  • BiVACOR Inc
  • BioVentrix Inc
  • Berlin Heart GmbH
  • LivaNova Plc
  • Jarvik Heart Inc
  • Who should buy this report?

    The North America Heart Transplant Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Heart Transplant Market value chain can benefit from the information contained in a comprehensive market report.